NSEAnalysts/Institutional Investor Meet/Con. Call Updates1d ago · 17 Sept 2026, 12:51 pm

Analysts/Institutional Investor Meet/Con. Call Updates

Cohance Lifesciences Limited · COHANCE

✦ AI SummaryMgmt Change

Cohance Lifesciences Limited has informed the Exchange about Schedule of Analysts/ Institutional Investors Meet, where the management will be attending JP Morgan India Conference in Mumbai and JP Morgan Roadshow in Hyderabad.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Cohance Lifesciences Limited has informed the Exchange about Schedule of Analysts/ Institutional Investors Meet

Attachments (1)

📄

SUVENPHARMROHIT_17092026125044_Cohance_Disclosure_Investor_Meet.pdf

pdf

Download →
View document text
17 September 2026 To To BSE Limited National Stock Exchange of India Limited 25th Floor, P. J. Towers, Exchange Plaza, Bandra Kurla Complex Dalal Street, Mumbai - 400 001 Bandra (E), Mumbai – 400 051 Code: 543064 Symbol: COHANCE Dear Sir/Madam, Sub: Intimation regarding Analysts/ Institutional Investors Meet Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please note that the management of the Company will be attending the below mentioned Conferences: Date Conference Location Group/One-one 22 September 2026 JP Morgan India Conference Mumbai Group and One-on-One 24 September 2026 JP Morgan Roadshow Hyderabad Group Note: The schedule of the aforesaid meets is subject to change. The change may happen due to exigencies on the part of Analyst/ Institutional Investor/ Company. No unpublished price-sensitive information will be shared during this interaction. You are requested to take the above on record. Thanking you. Yours faithfully, For Cohance Lifesciences Limited (formerly, Suven Pharmaceuticals Limited) Sisir K. Mishra Company Secretary & Compliance Officer